Innolake Biopharm logo

Innolake Biopharm

A clinical stage biotech company, aiming to provide innovative therapeutics in oncology and autoimmune disease areas.

5 employees · est. 2020 · Shanghai, China

VS
CORXEL Pharmaceuticals logo

CORXEL Pharmaceuticals

Our mission is to develop innovative cardiometabolic therapies globally.

40 employees · est. 2019 · Shanghai, China

CORXEL Pharmaceuticals is the older company (2020 vs 2019); CORXEL Pharmaceuticals is the larger of the two.

Side-by-Side Comparison

Innolake Biopharm CORXEL Pharmaceuticals
Founded
2020 2019 older
Headquarters
Shanghai, China Shanghai, China
Employees
5 40 larger
Industry
Biotechnology, Health and Wellness Biotechnology, Health Care
Funding Stage
Series A Series D
Total Funding
$400.00M $162.00M
Funding Rounds
2 2
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biotech Company, Oncology Therapeutics, Autoimmune Disease Therapeutics, Clinical Stage, Innovative Medicines, Proprietary Technology Platforms, R&D Capabilities, Drug Candidates, Clinical Development, Chinese Biopharmaceutical Industry, Unicorns Of China, Innovation In Biopharmaceuticals Biopharmaceutical, Innovation, Therapeutics, Clinical Development, Ophthalmology, Cardiovascular, Global Partnerships, Patient-Centric, Unmet Medical Needs, China Healthcare, RTW Investments
Website
innolakebio.com jixing.com
Innolake Biopharm logo

About Innolake Biopharm

Innolake Biopharm is a clinical stage biotech company based in China, focusing on innovative therapeutics in oncology and autoimmune disease areas. Founded in 2020 by industry veterans Dr. Mingde Xia and Mr. Robert Chen, the company has made significant strides in a short time. With a $40 million Se...

CORXEL Pharmaceuticals logo

About CORXEL Pharmaceuticals

Jixing Pharmaceuticals, founded in 2019, is a biopharmaceutical company based in Shanghai, China. The company's slogan, "Our mission is to develop novel therapeutics, bridging the innovation gap for patients in China," reflects its dedication to bringing innovative science and medicines to underserv...

We will tell you when either one moves

BounceWatch watches Innolake Biopharm and CORXEL Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Innolake Biopharm and CORXEL Pharmaceuticals — by email.

Frequently Asked Questions

Innolake Biopharm — A clinical stage biotech company, aiming to provide innovative therapeutics in oncology and autoimmune disease areas.. CORXEL Pharmaceuticals — Our mission is to develop innovative cardiometabolic therapies globally.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Innolake Biopharm has raised $400.00M while CORXEL Pharmaceuticals has raised $162.00M.
Innolake Biopharm and CORXEL Pharmaceuticals operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Innolake Biopharm with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Innolake Biopharm on 12 Sep 2024, and CORXEL Pharmaceuticals on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes